Precigen, Inc. ( PGEN) - Key Metrics
PGEN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.15 | $0.06 | -$0.05 | -$0.05 |
| 2026Q1 | $0.07 | -$0.03 | -$0.14 | -$0.14 |
| 2025Q4 | $0.01 | -$0.08 | -$0.07 | -$0.08 |
| 2025Q3 | $0.01 | -$0.49 | -$0.10 | -$0.10 |
| 2025Q2 | $0 | -$0.09 | -$0.06 | -$0.07 |
PGEN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 23.75 |
| 2026Q1 | 0% | -38.24 |
| 2025Q4 | 0% | -15.74 |
| 2025Q3 | 0% | -0.75 |
| 2025Q2 | 0% | -3.95 |
PGEN
Price: $6.10
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.07 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 4.3 million
Market Capitalization: 2.6 billion